Searched for
SINGLE INHALER
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsFrom a macro perspective, it is clearly a good time to be bullish. But as valuations remain high in parts of the market despite the recent ...- Delhi Hotel Fire: They gathered from Bengaluru and Rajasthan to be with ailing father; Eight are dead and he hasn't been toldDelhi fire news today: A family reunion in Delhi to be with a critically ill patriarch turned tragic when a fire engulfed a hotel, killing ...
- 'America would never...': China mall hosts ‘secretly eat in class’ contest and 2,000 adults showed upA Chinese shopping mall hosted a unique competition where over 2,000 participants raced to eat a bowl of rice soup in a mock classroom sett...
- For both the compulsive trader and careful investor: 25 stocks to watch if risk appetite returns; some with upside potential, some notIf the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 29%In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...
- How did Vincent Zampella, ‘Call of Duty’ creator, die? Cause of death revealed after fatal Ferrari crashCall of Duty creator Vincent Zampella died at 55 in a December 2025 single-car crash on Angeles Crest Highway. Trapped in his burning Ferra...
- Cipla launches inhalable insulin for diabetes careCipla has launched a new orally inhaled insulin powder for diabetes patients in India. This needle-free alternative to injections offers a ...
- Glenmark launches fixed-dose triple therapy for COPDGlenmark Pharmaceuticals has launched a groundbreaking nebulised triple therapy for COPD. This single, easy-to-use treatment combines three...
- US-based AptarGroup breaks ground for new pharma plant in Taloja, near MumbaiAptarGroup held a groundbreaking ceremony for a new pharmaceutical plant in Taloja, India. The facility expands AptarGroup's presence in th...
- Delhi HC upholds injunction against Glenmark PharmaSun Pharma Laboratories, a wholly-owned subsidiary of Sun Pharmaceutical Industries, and Glenmark are contesting over their right to use dr...
- Mankind Pharma enters exclusive pact to distribute AstraZeneca's anti-asthma drug Symbicort in IndiaAstraZeneca Pharma India has partnered with Mankind Pharma to exclusively distribute its anti-asthma drug Symbicort in India. AstraZeneca w...
- US unit of India's Cipla recalls six batches of bronchospasm inhalerIndian pharmaceutical company Cipla has recalled six batches of its Albuterol Sulfate HFA Inhalation Aerosol in the US due to a container d...
- GSK launches once daily, single inhaler-triple therapy for COPD patientsTrelegy is delivered via the innovative Ellipta inhaler that provides accurate dosing through its consistent dose delivery mechanism and is...
- Contrary orders by different judges on COVID issues tarnishes judiciary image: Kerala HC judgeCiting one such example of conflicting orders, Justice Kumar said while one judge of the high court had allowed engineering students' plea ...
- Keep Covid at bay! Homemade, single-layer masks effective in blocking cough dropletsThe material must not only be able to block the droplets, but also be comfortable.
- Homemade face masks work best with multiple layers of fabric, study findsWorldwide shortages of protective equipment have led the U.S. Centers for Disease Control and Prevention and other health authorities to re...
- Lupin seeks more time from commerce ministry to complete Indore SEZ projectCompany is setting up its pharma unit in Indore SEZ to manufacture pharmaceutical formulations - metered dose inhalers and dry powder inhal...
- Lupin gets USFDA nod for Asthma drugQuoting IQVIA MAT September data, Lupin said, the said Asthma drug had annual sales of around USD 474.5 million in the US.
- World Asthma Day: Long-term usage of inhalers can have adverse side effectsNot only prevalent in developed countries, but it is also a major problem in the developing countries.
Load More
